Spark Biomedical, a leader in neurostimulation technology, is advancing its mission to enhance clinical trial outcomes with the Sparrow Link platform, an extension of the Sparrow Ascent device. Sparrow Ascent provides a drug-free, non-invasive solution for managing opioid withdrawal symptoms via Transcutaneous Auricular Neurostimulation therapy and holds potential for broader neurological and psychiatric applications. The Sparrow Link platform introduces remote monitoring capabilities, addressing a critical need in clinical trials: ensuring participant compliance and generating reliable, regulatory-compliant data.